Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and implications for dermatological and allergological diseases.
Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. Buhl T, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2020 Aug;18(8):815-824. doi: 10.1111/ddg.14195. Epub 2020 Jul 27. J Dtsch Dermatol Ges. 2020. PMID: 32717116 Review.
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases.
Zillikens D, Derfler K, Eming R, Fierlbeck G, Goebeler M, Hertl M, Hofmann SC, Karlhofer F, Kautz O, Nitschke M, Opitz A, Quist S, Rose C, Schanz S, Schmidt E, Shimanovich I, Michael M, Ziller F. Zillikens D, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2007 Oct;5(10):881-7. doi: 10.1111/j.1610-0387.2007.06342.x. J Dtsch Dermatol Ges. 2007. PMID: 17910670 English, German.
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S. Hertl M, et al. J Dtsch Dermatol Ges. 2008 May;6(5):366-73. doi: 10.1111/j.1610-0387.2007.06602.x. Epub 2008 Jan 14. J Dtsch Dermatol Ges. 2008. PMID: 18201220 English, German.
Allergological approach to drug hypersensitivity reactions.
Przybilla B, Aberer W, Bircher AJ, Brehler R, Brockow K, Dickel H, Fuchs T, Hertl M, Mockenhaupt M, Pfaar O, Ring J, Sachs B, Vieluf D, Wedi B, Worm M, Zuberbier T, Merk HF. Przybilla B, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2008 Mar;6(3):240-3. doi: 10.1111/j.1610-0387.2007.06656.x. Epub 2008 Jan 17. J Dtsch Dermatol Ges. 2008. PMID: 18205837 Review. English, German. No abstract available.
B-cell-directed therapy for inflammatory skin diseases.
Nagel A, Hertl M, Eming R. Nagel A, et al. Among authors: hertl m. J Invest Dermatol. 2009 Feb;129(2):289-301. doi: 10.1038/jid.2008.192. J Invest Dermatol. 2009. PMID: 19148218 Free article. Review.
502 results